IRIS
BELFIORI, GIULIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.085
AS - Asia 1.549
NA - Nord America 1.309
SA - Sud America 200
AF - Africa 39
OC - Oceania 2
Totale 5.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.228
RU - Federazione Russa 1.116
SG - Singapore 609
CN - Cina 466
IT - Italia 273
RO - Romania 265
BR - Brasile 161
HK - Hong Kong 150
VN - Vietnam 115
DE - Germania 88
BD - Bangladesh 74
FR - Francia 68
GB - Regno Unito 56
CA - Canada 49
FI - Finlandia 48
IN - India 45
SE - Svezia 38
PL - Polonia 32
NL - Olanda 24
ES - Italia 23
MX - Messico 21
AT - Austria 20
AR - Argentina 18
ZA - Sudafrica 17
JP - Giappone 14
ID - Indonesia 11
TR - Turchia 11
EC - Ecuador 9
IQ - Iraq 9
LT - Lituania 8
MY - Malesia 8
IE - Irlanda 6
KE - Kenya 6
BE - Belgio 5
PH - Filippine 5
PK - Pakistan 5
UA - Ucraina 5
CO - Colombia 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
EG - Egitto 3
ET - Etiopia 3
HU - Ungheria 3
JM - Giamaica 3
MA - Marocco 3
NP - Nepal 3
PY - Paraguay 3
TW - Taiwan 3
AL - Albania 2
AU - Australia 2
DZ - Algeria 2
IL - Israele 2
IR - Iran 2
PA - Panama 2
QA - Qatar 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
BB - Barbados 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GR - Grecia 1
HN - Honduras 1
JO - Giordania 1
KH - Cambogia 1
KZ - Kazakistan 1
LY - Libia 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
SN - Senegal 1
TG - Togo 1
Totale 5.184
Salva come PNG Salva come JPEG
Città #
Singapore 358
Moscow 216
Ashburn 195
San Jose 166
Hong Kong 148
Dallas 117
New York 76
Beijing 68
Shanghai 67
Milan 62
Los Angeles 57
Hefei 44
Ho Chi Minh City 39
Lauterbourg 37
Boardman 36
Orem 36
São Paulo 29
Santa Clara 28
Rome 25
Council Bluffs 23
Hanoi 22
Helsinki 22
Nuremberg 22
Munich 21
Warsaw 21
Chicago 18
Montreal 18
Stockholm 18
Denver 17
Frankfurt am Main 17
Phoenix 17
Chennai 16
Poplar 15
Buffalo 13
Johannesburg 13
Lappeenranta 13
Turku 13
Atlanta 12
Brooklyn 12
Amsterdam 11
Brescia 11
Cesano Boscone 11
Toronto 11
Vienna 11
Guangzhou 9
Houston 9
London 9
Manchester 9
Mexico City 9
Pisa 9
Seattle 9
Tokyo 9
Assago 8
Boston 8
Ottawa 7
Perugia 7
Pune 7
Rio de Janeiro 7
Tianjin 7
Falkenstein 6
Hangzhou 6
Memphis 6
Brasília 5
Brussels 5
Calgary 5
Carlsbad 5
Dublin 5
Guayaquil 5
Jiaxing 5
Querétaro 5
San Francisco 5
Shenzhen 5
The Dalles 5
Verdellino 5
Ankara 4
Baghdad 4
Belo Horizonte 4
Bexley 4
Bologna 4
Cagliari 4
Charlotte 4
City of London 4
Da Nang 4
Dalian 4
Florence 4
Kuala Lumpur 4
Mumbai 4
Nairobi 4
Naples 4
Providence 4
St Louis 4
Tashkent 4
Thái Bình 4
Turin 4
Wroclaw 4
Bari 3
Biên Hòa 3
Cleveland 3
Columbus 3
Delhi 3
Totale 2.502
Salva come PNG Salva come JPEG
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 357
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 174
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 167
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 157
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 136
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 128
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 123
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 119
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 119
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 118
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis 115
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 114
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 113
Correction to: Intraperitoneal prophylactic drain after pancreaticoduodenectomy: an Italian survey (Updates in Surgery, (2024), 76, 3, (923-932), 10.1007/s13304-024-01836-0) 110
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 108
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 108
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 108
Hypofractionated radiotherapy concomitant to capecitabine after induction chemotherapy for advanced pancreatic adenocarcinoma 107
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 107
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 106
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 105
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 104
Personalized surveillance intervals for intraductal papillary mucinous neoplasm (IPMN): multicenter study using parametric models 103
ASO Visual Abstract: Surgery for IPMN of the Pancreas-Preoperative Factors Tipping the Scale of Decision-Making 102
Pathologic complete response following neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma: Impact on survival and recurrence 101
The role of biliary events in treatment and survival of patients with advanced pancreatic ductal adenocarcinoma 99
Italian Chronic Pancreatitis Registry (ITARECIPE): Protocol for a nationwide cohort study 99
Epidemiology, clinical features and diagnostic work-up of cystic neoplasms of the pancreas: Interim analysis of the prospective PANCY survey 97
Pancreatectomy with venous vascular resection for pancreatic cancer: Impact of types of vein resection on timing and pattern of recurrence 97
Endoscopic and Surgical Management of Non-Metastatic Ampullary Neuroendocrine Neoplasia: A Multi-Institutional Pancreas2000/EPC Study 96
Risk factors for the occurrence of ampullary tumors: A case-control study 94
Pancreatic resections for benign intraductal papillary mucinous neoplasms: Collateral damages from friendly fire 87
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease 85
Surgical Planning for “Borderline Resectable” and “Locally Advanced” Pancreatic Cancer During Open Pancreatic Resection 81
Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a “Biological R2 Definition” 79
Identification of patients with branch-duct intraductal papillary mucinous neoplasm and very low risk of cancer: multicentre study 79
Improving diagnostic accuracy and appropriate indications for surgery in pancreatic cystic neoplasms: the role of EUS 78
ASO Author Reflections: Long-Term Survivors after Upfront Resection for Pancreatic Cancer: Do They Really Exist? 75
Cure Probabilities After Resection of Pancreatic Ductal Adenocarcinoma: A Multi-Institutional Analysis of 2554 Patients 75
Pathological Complete Response in Patients With Resected Pancreatic Adenocarcinoma After Preoperative Chemotherapy 74
Continuous intraperitoneal insulin infusion as a valuable approach in patients with unstable type 1 diabetes: two case reports and a mini review of the literature 72
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 68
Pro-tumor Tfh2 cells induce detrimental IgG4 production and PGE2-dependent IgE inhibition in pancreatic cancer 68
Indications to total pancreatectomy for positive neck margin after partial pancreatectomy: a review of a slippery ground 68
Surgery for Intraductal Papillary Mucinous Neoplasms of the Pancreas: Preoperative Factors Tipping the Scale of Decision-Making 64
Prognostic Validation of Perineural Invasion Severity Score in Pancreatic Cancer: A Prospective Study 62
Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation 60
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 59
Real-world costs and dynamics of surveillance in patients who underwent surgery for low-risk branch duct intraductal papillary mucinous neoplasms 54
Clinical features and evolution of paraduodenal (groove) pancreatitis: A multicenter study 53
Preoperative prediction of metastatic body-tail peripancreatic lymph nodes as a guide for surgical decision-making in pancreatic neck ductal adenocarcinoma 50
TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength 48
Response to ‘Towards an individualized strategy in perioperative chemotherapy for pancreatic cancer’ 33
Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-institutional Analysis 27
Survival after neoadjuvant and induction FOLFIRINOX versus gemcitabine-nab-paclitaxel in patients with resected localised pancreatic adenocarcinoma: an international multicentre study 22
Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment 19
Clinico-pathological features and prognosis of mixed-IPMNs with a focal involvement of the main pancreatic duct 3
Real life management of intraductal papillary mucinous neoplasms of the pancreas: Final data from the prospective Italian pancreatic cysts (PANCY) registry 2
IgG4-related autoimmune pancreatitis mimicking a degenerating intraductal papillary mucinous neoplasm 2
ASO Visual Abstract: Risk Factors for Early Disease-Related Mortality Among Patients with Localized Pancreatic Cancer Resected After Neoadjuvant Treatment 2
ASO Author Reflections: Early Disease-Related Mortality After Neoadjuvant Therapy and Radical Resection for Pancreatic Ductal Adenocarcinoma—The Biological Burden Beyond Resectability 1
Totale 5.341
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.207
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.207
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 1 0 0 0 0 0 0 0 0
2022/202353 3 2 1 0 2 7 11 10 0 0 10 7
2023/2024237 3 12 27 31 23 39 11 22 3 0 31 35
2024/20251.160 62 20 41 66 73 77 391 103 123 51 66 87
2025/20263.889 220 192 129 418 379 136 330 359 1.052 242 256 176
Totale 5.341